T1	Participants 17 40	operable gastric cancer
T3	Participants 256 293	patients with operable gastric cancer
T5	Participants 755 810	Early gastric cancer or cardia carcinoma were excluded.
T6	Participants 1259 1307	56 eligible and evaluable patients were entered:
T2	Participants 496 753	Patients younger than 75 years of age with a good physical and mental condition and a histologically proven adenocarcinoma of the stomach without clinical or radiographic (computed tomography scan) evidence of distant metastases were eligible for this trial
